Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA
Clinical trial NCT02012998 · COMPLETED
Trial details
- NCT number
- NCT02012998
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 751
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.